Zobrazeno 1 - 10
of 20
pro vyhledávání: '"D. K., Galanakis"'
Publikováno v:
Thrombosis and haemostasis. 83(4)
Because it contains three pairs of polypeptides, fibrinogen isolated from heterozygous individuals is expected to be a mixture of homodimers and heterodimers. Nevertheless, heterozygous individuals with only homodimers have been identified. We synthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df0ebdebf3af9db26e7ee46ac76376ff
https://pubmed.ncbi.nlm.nih.gov/10780323
https://pubmed.ncbi.nlm.nih.gov/10780323
Publikováno v:
Blood. 90(7)
Fib420 is a recently identified subclass of normal human fibrinogen in which two extended alpha chain isoforms (alphaE) replace the common alpha chains, yielding a molecule (ca. 420 kD) which is larger than the more abundant 340-kD form. Evidence for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a649e686ed81d3e019a90cd38f2fb67
https://pubmed.ncbi.nlm.nih.gov/9326227
https://pubmed.ncbi.nlm.nih.gov/9326227
Autor:
D. K. Galanakis, E. I. B. Peerschke
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 7(3)
Evidence is emerging for the regulation of platelet function at sites of vascular injury or thrombosis by multiple platelet recognition sites in fibrinogen. This study examined the interaction of platelets with immobilized fibrinogen degradation prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da3825842f27b2e98415d4c39c291a1d
https://pubmed.ncbi.nlm.nih.gov/8735144
https://pubmed.ncbi.nlm.nih.gov/8735144
Autor:
B, Ghebrehiwet, D K, Galanakis
Publikováno v:
Behring Institute Mitteilungen. (93)
The serum C1q inhibitor (C1q INH) is a chondroitin 4-sulfate proteoglycan which is composed of several polyanionic components ranging in size from 21-750 kDa. Although the activity of C1q INH has been described in terms of its ability to precipitate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf8e55b8f0112bfed7bde48e6789c20e
https://pubmed.ncbi.nlm.nih.gov/8172570
https://pubmed.ncbi.nlm.nih.gov/8172570
Autor:
D K, Galanakis
Publikováno v:
Hematology/oncology clinics of North America. 6(5)
The precipitous increase in the number of structurally defined fibrinogen defects in recent years has resulted from application of high performance liquid chromatography in combination with peptide mapping and sequencing procedures. More recently, ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::077b3f7f47a822b6292210f83a2cfab2
https://pubmed.ncbi.nlm.nih.gov/1400080
https://pubmed.ncbi.nlm.nih.gov/1400080
Autor:
D K, Galanakis, M, Hultin
Publikováno v:
Blood coagulationfibrinolysis : an international journal in haemostasis and thrombosis. 1(4-5)
We describe preliminary studies of a new familial dysfibrinogen, fibrinogen Stony Brook II, present in a propositus and his mother. Both presented with a history of unexplained and chronic joint swelling following trauma, and the propositus suffered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49b4d3c03e490dfeb1f5c49fe4bb58db
https://pubmed.ncbi.nlm.nih.gov/2133235
https://pubmed.ncbi.nlm.nih.gov/2133235
Publikováno v:
Blood. 52:1037-1046
There is paucity of information regarding the prolonged plasma thrombin time known to occur in some patients with systemic lupus erythematosus. Detailed investigations of plasma from two such patients disclosed that IgG accounted for this defect in e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baef78eb33f9d7b9f28077e22e0e4bbb
https://doi.org/10.1182/blood.v52.5.1037.bloodjournal5251037
https://doi.org/10.1182/blood.v52.5.1037.bloodjournal5251037
Autor:
A. Henschen, D. K. Galanakis
Publikováno v:
Structural variants and interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a67d2c0309fb5273f87a0613c2972df1
https://doi.org/10.1515/9783110855951-021
https://doi.org/10.1515/9783110855951-021
Publikováno v:
Annals of clinical and laboratory science. 9(5)
Two new commercial assays for the detection of degradation products of fibrinogen/fibrin (FDP) were evaluated against two standard procedures. The first, a new hemagglutination inhibition (HAI) assay using glutaraldehyde-treated cells, was compared w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::08d2170bc262bbdf6622e3560d4ce1f5
https://pubmed.ncbi.nlm.nih.gov/533231
https://pubmed.ncbi.nlm.nih.gov/533231
Autor:
E I, Peerschke, D K, Galanakis
Publikováno v:
The Journal of laboratory and clinical medicine. 101(3)
Fibrinogen supports platelet aggregation by binding to specific receptors. The importance of the fibrinogen A alpha chain in this hemostatic function is controversial. We found that fibrinogen derivatives, isolated from plasma or obtained after limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c71c69836a4607d04a697d4d1ca922a
https://pubmed.ncbi.nlm.nih.gov/6827176
https://pubmed.ncbi.nlm.nih.gov/6827176